CLSA has downgraded HPCL to sell from outperform, with increased target price at Rs 540 from Rs 480 and EPS for FY17 by 8 percent & by 1-2 percent for FY18-19. Core refining margin was disappointing for third straight quarter, the brokerage house says, adding it relaxed EV/EBITDA multiple to 7.5x from 7x earlier.
GlaxoSmithKline (GSK) Consumer Healthcare Ltd today reported a 8.25 per cent decline in its standalone net profit at Rs 136.41 crore for the third quarter ended on December 31, 2016, on the account of lower sales.
Kotak's preferred picks are ITC, Britannia Industries, Colgate Palmolive, GSK Consumer and Bajaj Corp.
On November 30, 2016 Blackrock Global Opportunitiesequity Trust sold 2,84,334 shares of GlaxoSmithKline Consumer Healthcare.
In an interview to CNBC-TV18, Nikhil Vora, Founder & CEO of Sixth Sense Ventures spoke about various stocks and sectors and also shared his readings and outlook on demonetisation.
Nomura has a buy rating on ICICI with target price at Rs 325 per share as watchlist resolution was on expected lines in Q2.
ICICI Bank | Heritage Foods | Varun Beverages | BHEL | EID Parry | Britannia | Asahi India Glass | Asahi Songwon | Tata Metaliks | Dish TV | Sun TV | Den Networks | Hotel Leela and Everonn Education are stocks, which are in the news today.
GlaxoSmithKline Consumer Healthcare Ltd today reported 16.62 per cent decline in standalone net profit at Rs 183.72 crore for the second quarter ended September 30, 2016.
Country's seven leading FMCG companies have fared better than their multinational peers in terms of revenue growth in India during 2015-16 fiscal, says a report.
Net Sales are expected to increase by 16.1 percent Q-o-Q (down 2.7 percent Y-o-Y) to Rs 1095.5 crore, according to Centrum.
Abhay Laijawala of Deutsche Bank says with record Kharif output likely to give significant boost to rural consumption sentiment and other factors such as 7th Central Pay Commission also supporting aggregate demand in the economy, it will likely result in consensus upgrades to earnings of consumer and rural interfacing sectors and stocks.
Be prepared. India is likely to see positive confidence shock with consumer discretionary and retail financiers to be benefitting the most. According to Abhay Laijawala of Deutsche Bank Multiple 7th Pay Commission, good monsoon, low interest rates and easing liquidity should provide a significant boost to aggregate demand in second half of FY17.
Potential stock beneficiaries include Bajaj Finserv, GSK Consumer, Hero Motocorp, LIC Housing Finance, Titan Company and Whirlpool India, Abhay Laijawala of Deutsche Bank feels.
Prabhudas Lilladher has recommended accumulate rating on GSK Consumer with a target price of Rs 6524 in its research report dated August 05, 2016.
GlaxoSmithKline Consumer Healthcare Ltd today reported a 2.92 percent increase in net profit at Rs 160.61 crore for the first quarter ended June 30, 2016-17.
The company had posted net profit of Rs 156.05 crore in the same period of last fiscal, GSKCH said in a BSE filing.
"Next batch of June corporate results, progress of monsoon rains, sentiments in global markets will set the market trend this week. Investors will continue to watch developments on the Goods and Services Tax (GST) constitutional amendment bill in Parliament," said Vijay Singhania, Founder-Director, Trade Smart Online.
Net Sales are expected to up 2 percent Y-o-Y to Rs 1010.1 crore, according to Axis Securities
NTPC | Wipro | 3i Infotech | IL&FS Transportation | Andrew Yule | Crompton Greaves | Lux Industries | Premier Explosives | Ujjivan | Bombay Rayon | Deccan Cements | Pricol | Info Edge and GSK Consumer are stocks, which are in the news today.
GlaxoSmithKline Consumer Healthcare said it has resumed operations at its manufacturing facility at Nabha in Punjab
Deepak Shenoy, Capitalmind.in is upbeat on the rural agro plays like Godrej Consumers, PI Industries from hereon.
"Due to certain disruptions created by the workforce/ flash strike... the management of the company has decided to suspend operations temporarily at its factory located at Nabha Patiala - 147201 with effect from the night of May 21, 2016," GSK Consumer Healthcare said in a BSE filing today.
Emkay is bullish on GSK Consumer has recommended accumulate rating on the stock with a target price of Rs 6200 in its research report dated May 19, 2016.
Watch the interview of SP Tulsian of sptulsian.com with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
The company had posted a net profit of Rs 196.78 crore for the corresponding period a year ago, GSK said in a BSE filing.